Search - tctmd.com

Displaying 741 - 760 of 1337

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

Presentation TCT 2013

Case 3: Radial Access and Intervention in the Post-CABG Patient

Presenter: Olivier Bertrand

October 31, 2013

Presentation TCT 2013

Case #3 - STEMI With a Distal Left Main Coronary Artery Culprit Lesion and Cardiogenic Shock: Is CABG a Viable Option?

Presenter: Vjekoslav Tomulic

October 31, 2013

News Industry News

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

October 31, 2013

News Conference News TCT 2013

HYBRID: Hybrid Revascularization Shows Safety, Effectiveness vs. CABG in Multivessel CAD

October 31, 2013

News Conference News TCT 2013

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

October 31, 2013

News Industry News

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

October 31, 2013

Presentation TCT 2013

Diabetes Mellitus and Multivessel Disease: CABG for All!

Presenter: Craig Smith

October 30, 2013

Presentation TCT 2013

Left Main PCI vs. CABG: Differentiating Patient and Clinical Features

Presenter: Corrado Tamburino

October 30, 2013

Presentation TCT 2013

Case Presentation #4: Subclavian Steal: A Tale of CABG Followed by CHF

Presenter: Uri Rosenschein

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Industry News

Trial Examines Benefits of Using a New Test to Determine the Severity of Coronary Artery Disease

October 30, 2013

News Industry News

Study Demonstrates High Accuracy of Non-Invasive Computed FFR in Evaluating

October 30, 2013

News Conference News TCT 2013

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

October 30, 2013

News Conference News TCT 2013

PCI vs. CABG a Close Call in Some Complex Patients

October 30, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

Presentation TCT 2013

Why I Believe CABG Is (Usually) Better for My Patients

Presenter: Joseph Sabik

October 29, 2013

Presentation TCT 2013

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Presenter: Dean Kereiakes

October 29, 2013

Advertisement

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Case 3: Radial Access and Intervention in the Post-CABG Patient

Case #3 - STEMI With a Distal Left Main Coronary Artery Culprit Lesion and Cardiogenic Shock: Is CABG a Viable Option?

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

HYBRID: Hybrid Revascularization Shows Safety, Effectiveness vs. CABG in Multivessel CAD

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

Diabetes Mellitus and Multivessel Disease: CABG for All!

Left Main PCI vs. CABG: Differentiating Patient and Clinical Features

Case Presentation #4: Subclavian Steal: A Tale of CABG Followed by CHF

Two Trials to Assess TAVR in Moderate-Risk Patients

Trial Examines Benefits of Using a New Test to Determine the Severity of Coronary Artery Disease

Study Demonstrates High Accuracy of Non-Invasive Computed FFR in Evaluating

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

PCI vs. CABG a Close Call in Some Complex Patients

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Why I Believe CABG Is (Usually) Better for My Patients

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content